Related Experiment Videos
The secondary prevention of coronary artery disease
C N Merz1, A Rozanski, J S Forrester
1Department of Medicine, Cedars-Sinai Research Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.
Insights
Medical secondary prevention programs, including exercise and lifestyle changes, offer significant risk reduction for coronary disease patients. These interventions stabilize or reverse disease progression, improving quality of life and reducing mortality.
Area of Science:
- Cardiology
- Preventive Medicine
- Clinical Trials
Background:
- Randomized clinical trials confirm the effectiveness of medical secondary prevention strategies in patients with coronary heart disease.
- These strategies encompass exercise, diet modification, lipid management, and smoking cessation.
- The risk reduction achieved is comparable to established medical therapies like aspirin and beta-blockers, and even coronary bypass surgery.
Purpose of the Study:
- To evaluate the efficacy of medical secondary prevention in coronary disease patients.
- To compare the impact of secondary prevention on angiographic progression and patient outcomes with other treatments.
- To highlight the endorsement of secondary prevention by major cardiology organizations.
Main Methods:
- Review of randomized clinical trials on secondary prevention in coronary disease.
- Analysis of data on risk reduction, angiographic progression, symptom improvement, and quality of life.
- Assessment of clinical guidelines and recommendations from professional organizations.
Main Results:
- Secondary prevention demonstrates efficacy comparable to other coronary disease therapies.
- Approximately 50% of patients experience stabilization of angiographic progression, with regression in about 25%.
- Beneficial effects on symptoms and quality of life are observed, though potentially less pronounced than with bypass surgery.
Conclusions:
- Medical secondary prevention is strongly endorsed by the American Heart Association and the American College of Cardiology.
- Widespread implementation could significantly decrease coronary mortality and morbidity in the 12 million established coronary disease patients.
- Secondary prevention offers a powerful approach to managing coronary heart disease progression and improving patient well-being.
Abstract:
Randomized clinical trials demonstrate the efficacy of medical secondary prevention in coronary disease patients. The magnitude of risk reduction with exercise, diet, lipid modification, and smoking cessation is similar to other medical therapies for coronary disease such as aspirin, beta blockers, as well as coronary bypass surgery, (Table VI) In contrast to these therapies, however, secondary prevention stabilizes angiographic progression in about 50% of patients and induces regression in about 25% of patients. Both symptoms and perceived quality of life also are beneficially altered by secondary prevention programs, although possibly not by the magnitude reported for bypass surgery. These clinical trial results have led the American Heart Association, and the American College of Cardiology to strongly endorse secondary prevention. A reasonable projection based on these clinical trial data is that widespread use of these recommendations in the 12 million established coronary disease patients would significantly reduce coronary mortality and morbidity.